Well those 8% would now buy 50% of the company
Putting back the time line for a product is never good - period, and having a compound being handed back twice by 2 separate entities is virtually a death sentence, sorry
And yes - the MD is to blame : handed the outsourcing to Destum for once.........................
See of we get to see the data of the higher dose trial and if anyone is willing to touch 1103
Guess we will see how the market reacts once the TH is lifted
In relation to the ATL1103 program, page-88
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $121.7M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.0¢ | $378.0K | 2.903M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 516956 | 4 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |